Has another trial getting underway. They want to try the drug in metestatic colerectal cancer. I also looked at LEE011 and they added another trial with that drug. That makes 8 trials. Could novaritis being the one that buys astex out? CEO isn't getting any younger. I believe with the dacogen generic news, CEO may accept an offer.
Thanksfor the update Free. On LEE-011, they have started a trial that is for Asian patients with advanced solid tumors. Not sure if I have seen a trial that targets one particular group. Sure that it has happended. I have not seen it. Interesting thought on Novaritis. As you said, they are up to 8 trials with LEE-011. Looks like Novaritis is throwing everything against the wall and sees what sticks. At the JMP presentation yesterday, Astex highlighted LEE-011 yesterday on its own slide for the first time.